BRIEF published on 04/07/2025 at 20:19, 11 months 17 days ago GenSight Biologics Financial and Business Update Fundraising Clinical Trials Gene Therapy Financial Update GenSight Biologics
BRIEF published on 04/07/2025 at 20:19, 11 months 17 days ago Mise à jour financière et commerciale de GenSight Biologics Essais Cliniques Thérapie Génique Mise À Jour Financière Collecte De Fonds GenSight Biologics
PRESS RELEASE published on 04/07/2025 at 20:14, 11 months 17 days ago Inside Information / News release on accounts, results GenSight Biologics reports cash position and business update as of March 31, 2025. Discussions with French agency progressing. Fundraising planned for Phase III trial and marketing advancement Business Update Cash Position Fundraising Activities GenSight Biologics RECOVER Phase III Trial
PRESS RELEASE published on 04/07/2025 at 20:14, 11 months 17 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 31 mars 2025, annonce des activités de levées de fonds pour prolonger l'horizon de trésorerie et fait le point sur ses activités Trésorerie Essai Clinique GenSight Biologics Thérapies Géniques Levées De Fonds
BRIEF published on 03/17/2025 at 07:35, 1 year ago GenSight Biologics Présente LUMEVOQ® au Congrès NANOS 2025 Thérapie Génique GenSight Biologics LUMEVOQ® NOHL Congrès NANOS
BRIEF published on 03/17/2025 at 07:35, 1 year ago GenSight Biologics Presents LUMEVOQ® at NANOS 2025 Gene Therapy GenSight Biologics LUMEVOQ® NOHL NANOS Congress
PRESS RELEASE published on 03/17/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2025 du NANOS. Nouvelles données sur la thérapie génique pour NOHL Thérapie Génique GenSight Biologics NOHL LUMEVOQ NEURO-OPHTALMOLOGIE
PRESS RELEASE published on 03/17/2025 at 07:30, 1 year ago Inside Information / Other news releases GenSight Biologics will present scientific updates on LUMEVOQ gene therapy at NANOS 2025, including real-world experience and long-term outcomes for LHON treatment Gene Therapy GenSight Biologics LHON LUMEVOQ NANOS 2025
BRIEF published on 03/07/2025 at 08:34, 1 year ago GenSight Biologics Secures €0.9 Million Financing from Existing Investors Investors Financing Gene Therapy GenSight Biologics Retinal Diseases
BRIEF published on 03/07/2025 at 08:34, 1 year ago GenSight Biologics obtient un financement de 0,9 million d'euros auprès d'investisseurs existants Financement Investisseurs Thérapie Génique GenSight Biologics Maladies De La Rétine
Published on 03/25/2026 at 04:50, 38 minutes ago Arctic Fox Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 03/24/2026 at 23:00, 6 hours 28 minutes ago Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 10 hours 33 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 15 hours 58 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 21:08, 8 hours 20 minutes ago Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 9 hours 39 minutes ago EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 9 hours 47 minutes ago ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 10 hours 23 minutes ago WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 10 hours 49 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 17:46, 11 hours 42 minutes ago NRJ GROUP - Press release annual results 2025
